Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer - Miles, D; Gligorov, J; André, F (Ann Oncol, 2021)
et al.